11:19:09 EST Mon 16 Nov 2026
Enter Symbol
or Name
USA
CA



CANNARA BIOTECH INC
Symbol LOVE
Shares Issued 98,673,264
Close 2026-11-13 C$ 2.03
Market Cap C$ 200,306,726
Recent Sedar+ Documents

ORIGINAL: Cannara to Announce Fiscal Q4 and Fiscal Year 2026 Financial Results on November 30, 2026

2026-11-16 08:00 ET - News Release

MONTREAL, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, the “Company”, “us” or “we”) (TSX: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities in Québec spanning over 1,600,000 sq. ft., today announced that it will release its financial results for the fiscal fourth quarter and fiscal year ended August 31, 2026, on Monday, November 30, 2026, at 8:00 AM ET.

The Company will host an earnings webcast on Monday, November 30, 2026, at 11:00 AM ET, consisting of prepared remarks followed by a question-and-answer session.

Participants may register to attend the earnings webcast via a webcast link or via local dial-in as follows:

Webcast:Cannara Q4 and Fiscal 2026 Earnings Webcast Registration
Local Dial-in:Cannara Q4 and Fiscal 2026 Earnings Webcast Dial-in Registration


Investors are encouraged to submit questions by email in advance to investors@cannara.ca. For interested individuals unable to join, the event will be archived on the company’s website.

CONTACT

Scott Carroll, PhD, MBA
Vice President, Investor Relations & Commercial Strategy
scott.carroll@cannara.ca


ABOUT CANNARA

Cannara Biotech Inc. (TSX: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products. Cannara owns two mega facilities based in Québec spanning over 1,600,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s favourable energy costs, Cannara maintains an efficient, low-cost production model. For more information, please visit cannara.ca. 


Primary Logo

© 2026 Canjex Publishing Ltd. All rights reserved.